X0202 4 2005-02-08 0 0000902622 ICAGEN INC ICGN 0001106605 J P MORGAN PARTNERS SBIC LLC C/O J.P. MORGAN PARTNERS 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 0 0 1 0 0001106607 JP MORGAN PARTNERS BHCA LP J.P. MORGAN PARTNERS 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 0 0 1 0 0001243235 JPMP MASTER FUND MANAGER L P JP MORGAN PARTNERS LLC 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 0 0 1 0 0001243236 JPMP CAPITAL CORP C/O J.P. MORGAN PARTNERS, LLC 1221 AVENUE OF THE AMERICAS 40TH FLOOR NEW YORK NY 10020 0 0 1 0 Common Stock 2005-02-08 4 C 0 479600 0 A 479600 D Common Stock 2005-02-08 4 C 0 36668 0 A 516268 D Common Stock 2005-02-08 4 C 0 36668 0 A 552936 D Common Stock 2005-02-08 4 C 0 580402 0 A 580402 I See footnote Common Stock 2005-02-08 4 C 0 44374 0 A 624776 I See footnote Common Stock 2005-02-08 4 C 0 133120 0 A 757896 I See footnote Series F Preferred Stock 2005-02-08 4 C 0 479600 D Common Stock 479600 0 D Series G-1 Preferred Stock 2005-02-08 4 C 0 19556 D Common Stock 36668 0 D Series H Preferred Stock 2005-02-08 4 C 0 36668 D Common Stock 36668 0 D Series F Preferred Stock 2005-02-08 4 C 0 580402 D Common Stock 580402 0 I See footnote Series G-1 Preferred Stock 2005-02-08 4 C 0 23666 D Common Stock 44374 0 I See footnote Series H Preferred Stock 2005-02-08 4 C 0 133120 D Common Stock 133120 0 I See footnote The amounts shown represent the beneficial ownership of the Issuer's equity securities by Icagen Chase Partners (Alta Bio), LLC ("ICP"). The Reporting Person is a non-managing member of ICP. As a result thereof, the Reporting Person does not have voting or investment power over the shares owned by ICP and, therefore, is not the beneficial owner of the shares held by ICP within the meaning of Section 13(d) of the Securities Exchange Act of 1934, as amended. As a non-managing member of ICP, the Reporting Person has an indirect pecuniary interest in the shares beneficially owned by ICP and disclaims any beneficial ownership in such shares to the extent it exceeds its pecuniary interest therein. Upon the closing of the Issuer's initial public offering of Common Stock, these shares were automatically converted into Common Stock of the Issuer on a 1 for 1 basis. Upon the closing of the Issuer's initial public offering of Common Stock, these shares were automatically converted into Common Stock on a 1 for 1.875 basis. Each of the Series F, G-1, and H Preferred Stock is immediately exercisable. None of such Series has an expiration date. Not applicable. J.P. Morgan Partners (SBIC), LLC By: /s/ Jeffrey C. Walker President 2005-02-10